Following a proposal by the representatives of Austria and Denmark, the Executive Committee, mindful of the decisions taken at its Eighth, Fifteenth and Sixteenth Meetings, and recognizing the significant efforts of the implementing agencies and ODS offices in Article 5 countries in applying those decisions, decided that the following should be taken into account when preparing projects:
(a) As HCFCs were not controlled substances for Article 5 countries, incremental costs for conversion of HCFC-141b plants were not eligible for funding;
(b) Implementing agencies should note a presumption against HCFCs when preparing projects; and
(c) Where HCFC projects were proposed, the choice of this technology should be fully justified and include an estimate of the potential future costs of second-stage conversion.